Improve your Antibody Profiling Assays! - PepStar™ Peptide Microarrays

Antibody responses are central to protection following infection, vaccination, and immunotherapy. Accurate and reliable serological monitoring over time is essential; not only to evaluate therapeutic success, but also to understand seroprevalence and gain deeper insights into disease mechanisms. 

PepStar™ Peptide Microarrays have emerged as a powerful tool for high-resolution antibody profiling, enabling epitope-specific identification of antibody binding sites across individual antigens or entire proteomes. JPT is a global leader in high-quality peptide microarrays, offering both off-the-shelf and fully customized peptide solutions, along with comprehensive assay services to support your research from start to finish. 

Key Applications 

• Antibody response profiling 
• Biomarker discovery 
• Serological assay development 
• Antibody epitope mapping 
• Protein interaction validation 
• Immune monitoring 

Why choose our modular assay services? 

• Broad compatibility: Suitable for antibodies, serum, lysates, and other complex biological samples 
• Flexible design: Customizable peptide content and array formats tailored to your experimental needs 
• Quality standards: Production processes regulated by a certified quality management system. 
• Integrated bioinformatics: Expert support for array design, data analysis, and interpretation 

From experimental design to data evaluation, our team works closely with you to ensure optimal results at every stage. 

Selected References: 

1. Transthyretin stabilizer therapy increases naturally-occurring antibodies in ATTR cardiomyopathy
   Settelmeier et al., The Journal of Protein Folding Disorders (2026) 
2. Linear and conformational epitopes of Vicilin-buried peptides as a model for improved nut allergy diagnostics
   Swientoniewski et al., TechRxiv (2025) 
3. A Pentavalent HIV-1 Subtype C Vaccine Containing Computationally Selected gp120 Strains Improves the Breadth of V1V2 Region Responses
   Shen et al., Vaccines (2025) 
4. Affinity maturation and optimization of CD44v6-targeting antibodies for molecular radiotherapy Lundgren
   Mortensen et al., Nuclear Medicine and Biology (2025) 
5. Divergent antibody recognition profiles are generated by protective mRNA vaccines against Marburg and Ravn viruses
   Meyer et al., Nature Communications (2025) 

Take a look at how other publications are making use of our peptide microarrays!